메뉴 건너뛰기




Volumn 47, Issue 1, 2013, Pages 106-111

Nitrofurantoin contraindication in patients with a creatinine clearance below 60 mL/min: Looking for the evidence

Author keywords

[No Author keywords available]

Indexed keywords

NITROFURANTOIN;

EID: 84872903257     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R352     Document Type: Article
Times cited : (66)

References (24)
  • 1
    • 79951831698 scopus 로고    scopus 로고
    • International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Soci-ety of America and the European Society for Microbiology and Infec-tious Diseases
    • Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Soci-ety of America and the European Society for Microbiology and Infec-tious Diseases. Clin Infect Dis 2011;52:e103-e120.
    • (2011) Clin Infect Dis , vol.52
    • Gupta, K.1    Hooton, T.M.2    Naber, K.G.3
  • 2
    • 84858650295 scopus 로고    scopus 로고
    • In vitro antimicro-bial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010
    • Sanchez G V, Master RN, Karlowsky JA, Bordon JM. In vitro antimicro-bial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrob Agents Chemother 2012;56:2181-2183.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 2181-2183
    • Sanchez, G.V.1    Master, R.N.2    Karlowsky, J.A.3    Bordon, J.M.4
  • 3
    • 33646837506 scopus 로고    scopus 로고
    • Sulfonamides, trimethoprim-sulfamethoxazole, quinolones, and agents for urinary tract infections
    • In: Brunton LL, Lazo JS, Parker KL, eds., 11th ed. New York: McGraw-Hill
    • Petri WA. Sulfonamides, trimethoprim-sulfamethoxazole, quinolones, and agents for urinary tract infections. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's the pharmacological basis of therapeu-tics. 11th ed. New York: McGraw-Hill, 2006:1111-1126.
    • (2006) Goodman and Gilman's the Pharmacological Basis of Therapeu-tics , pp. 1111-1126
    • Petri, W.A.1
  • 4
    • 0017833324 scopus 로고
    • The pharmacokinetics of nitrofurantoin and its related bioavailability
    • Conklin JD. The pharmacokinetics of nitrofurantoin and its related bioavailability. Antibiot Chemother 1978;25:233-252.
    • (1978) Antibiot Chemother , vol.25 , pp. 233-252
    • Conklin, J.D.1
  • 5
    • 49649116465 scopus 로고
    • Nitrofurantoin. Clinical and laboratory studies in urinary tract infections
    • Richards WA, Riss E, Kass EH, Finland M. Nitrofurantoin. Clinical and laboratory studies in urinary tract infections. Arch Intern Med 1955;96:437-450.
    • (1955) Arch Intern Med , vol.96 , pp. 437-450
    • Richards, W.A.1    Riss, E.2    Kass, E.H.3    Finland, M.4
  • 7
    • 84872964090 scopus 로고    scopus 로고
    • Product information, Cincinnati, OH: Procter & Gamble Pharmaceuticals
    • Product information. Macrobid (nitrofurantoin monohydrate/macrocrys-tals). Cincinnati, OH: Procter & Gamble Pharmaceuticals, January 2009.
    • (2009) Macrobid (nitrofurantoin Monohydrate/macrocrys-tals)
  • 8
    • 84872968963 scopus 로고
    • Product information, Nor-wich, NY: Norwich Eaton Pharmaceuticals Inc, accessed 2012 Jul 19
    • Product information. Macrodantin (nitrofurantoin microcrystals). Nor-wich, NY: Norwich Eaton Pharmaceuticals Inc., May 1988. www.access data.fda.gov/drugsatfda_docs/nda/pre96/016620_S045_MACRO DANTIN_PRNTLBL.pdf (accessed 2012 Jul 19).
    • (1988) Macrodantin (nitrofurantoin Microcrystals)
  • 9
    • 84872971779 scopus 로고    scopus 로고
    • Product information, Cincinnati, OH: Procter & Gamble Pharmaceuticals
    • Product information. Macrobid (nitrofurantoin monohydrate/macrocrys-tals). Cincinnati, OH: Procter & Gamble Pharmaceuticals, March 2003. www.accessdata.fda.gov/drugsatfda_docs/Label/2003/20064slr014_macro bid_lbl.pdf (accessed 2012 Jul 19).
    • (2003) Macrobid (nitrofurantoin Monohydrate/macrocrys-tals)
  • 11
    • 84872911306 scopus 로고    scopus 로고
    • Nitrofurantoin, Greenwood Village, CO: Thomson Healthcare
    • Nitrofurantoin. DrugPoints system. Greenwood Village, CO: Thomson Healthcare. www.thomsonhc.com (accessed 2012 Jul 16).
    • (2012) DrugPoints System
  • 12
    • 44949180108 scopus 로고    scopus 로고
    • Contemporary management of uncomplicated urinary tract infections
    • Guay DRP. Contemporary management of uncomplicated urinary tract infections. Drugs 2008;68:1169-1205.
    • (2008) Drugs , vol.68 , pp. 1169-1205
    • Guay, D.R.P.1
  • 13
    • 0014352307 scopus 로고
    • Nitrofurantoin in renal failure (letter)
    • Glascock HW. Nitrofurantoin in renal failure (letter). Ann Intern Med 1968;69:1077.
    • (1968) Ann Intern Med , vol.69 , pp. 1077
    • Glascock, H.W.1
  • 14
    • 0014407602 scopus 로고
    • Effect of renal function on urinary recovery of orally administered nitrofurantoin
    • Sachs J, Geer T, Noell P, Kunin CM. Effect of renal function on urinary recovery of orally administered nitrofurantoin. New Engl J Med 1968; 278:1032-1035.
    • (1968) New Engl J Med , vol.278 , pp. 1032-1035
    • Sachs, J.1    Geer, T.2    Noell, P.3    Kunin, C.M.4
  • 15
    • 0008327835 scopus 로고
    • Peripheral neuropathy due to nitrofurantoin
    • Loughridge LW. Peripheral neuropathy due to nitrofurantoin. Lancet 1962;2:1133-1135.
    • (1962) Lancet , vol.2 , pp. 1133-1135
    • Loughridge, L.W.1
  • 17
    • 78651034701 scopus 로고
    • Theory concerning recur-rence of urinary infection: Prolonged administration of nitrofurantoin for prevention
    • Lippman RW, Wrobel CJ, Rees R, Hoyt R. Theory concerning recur-rence of urinary infection: prolonged administration of nitrofurantoin for prevention. J Urol 1958;80:77-81.
    • (1958) J Urol , vol.80 , pp. 77-81
    • Lippman, R.W.1    Wrobel, C.J.2    Rees, R.3    Hoyt, R.4
  • 18
    • 0015119473 scopus 로고
    • Neural, hematologic and bac-teriologic effects of nitrofurantoin in renal insufficiency
    • Felts JH, Hayes DM, Gergen JA, Toole JF. Neural, hematologic and bac-teriologic effects of nitrofurantoin in renal insufficiency. Am J Med 1971; 51:331-339.
    • (1971) Am J Med , vol.51 , pp. 331-339
    • Felts, J.H.1    Hayes, D.M.2    Gergen, J.A.3    Toole, J.F.4
  • 19
    • 70449717479 scopus 로고    scopus 로고
    • A retrospective review assessing the effica-cy and safety of nitrofurantoin in renal impairment
    • Bains A, Buna D, Hoag NA. A retrospective review assessing the effica-cy and safety of nitrofurantoin in renal impairment. Can Pharm J 2009; 142:242-248.
    • (2009) Can Pharm J , vol.142 , pp. 242-248
    • Bains, A.1    Buna, D.2    Hoag, N.A.3
  • 20
    • 0014274555 scopus 로고
    • Urinary excretion of nalidixic acid, sulfamethizole and nitrofurantoin in patients with reduced renal function
    • Goff JB, Schlegel JU, O'Dell RM. Urinary excretion of nalidixic acid, sulfamethizole and nitrofurantoin in patients with reduced renal function. J Urol 1968;99:371-375.
    • (1968) J Urol , vol.99 , pp. 371-375
    • Goff, J.B.1    Schlegel, J.U.2    O'Dell, R.M.3
  • 21
    • 0035057158 scopus 로고    scopus 로고
    • An update on the role of nitrofurans in the management of uri-nary tract infections
    • Guay DR. An update on the role of nitrofurans in the management of uri-nary tract infections. Drugs 2001;61:353-364.
    • (2001) Drugs , vol.61 , pp. 353-364
    • Guay, D.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.